Superoxide does not inhibit glyceryl trinitrate-rabbit aortic strip- mediated relaxation of rabbit Taenia coli: Evidence against a role for nitric oxide itself as the smooth muscle active drug metabolite?

Drug Metabolism and Disposition

Volumn 24, Issue 7, 1996, Pages 780-785

  Hussain, Aman S ^a   Brien, James F ^a   Marks, Gerald S ^a   Nakatsu, Kanji ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; DRUG METABOLITE; GLYCERYL TRINITRATE; HYDROQUINONE; NITRIC OXIDE; SUPEROXIDE; XANTHINE; XANTHINE OXIDASE;

ANGINA PECTORIS; ANIMAL TISSUE; AORTA; ARTICLE; COLON TENIA; CONGESTIVE HEART FAILURE; DRUG TRANSFORMATION; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; BIOTRANSFORMATION; MALE; MOLSIDOMINE; MUSCLE RELAXATION; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROGLYCERIN; OXIDATION-REDUCTION; RABBITS; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS; XANTHINE; XANTHINE OXIDASE; XANTHINES;

EID: 0030016177     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. J. F. Brien, B. E. McLaughlin, T. H. Breedon, B. M. Bennett, K. Nakatsu, and G. S. Marks: Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. J. Pharmacol. Exp. Ther. 237, 608-614 (1986).
2. L. J. Ignarro, H. Lippton, J. C. Edwards, W. H. Baricos, A. L. Hyman, P. J. Kadowitz, and C. A. Gruetter: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218, 739-749 (1981).
3. J. F. Brien, B. E. McLaughlin, S. M. Kobus, J. H. Kawamoto, K. Nakatsu, and G. S. Marks: Mechanism of glyceryl trinitrate induced vasodilation. I. Relationship between drug biotransformation, tissue cGMP elevation and relaxation of rabbit aorta. J. Pharmacol. Exp. Ther. 244, 322-327 (1988).
4. J. F. Kawamoto, B. E. McLaughlin, J. F. Brien, G. S. Marks, and K. Nakatsu: Biotransformation of glyceryl trinitrate and elevation of cGMP precede glyceryl trinitrate-induced relaxation of isolated blood vessels. J. Cardiovasc. Pharmacol. 15, 714-719 (1990).
5. A. S. Hussain, M. Poklewska-Koziell, J. F. Brien, G. S. Marks, and K. Nakatsu: Nitric oxide release from glyceryl trinitrate by rabbit aortic strip: detection by rabbit Taenia coli concurrent with vasorelaxation. Br. J. Pharmacol. 113, 1508-1514 (1994).
6. G. S. Marks, B. E. McLaughlin, K. Nakatsu, and J. F. Brien: Direct evidence for nitric oxide formation from glyceryl trinitrate during incubation with intact bovine pulmonary artery. Can. J. Physiol. Pharmacol. 70, 308-311 (1992).
7. G. S. Marks, B. E. McLaughlin, S. L. Jimmo, M. Poklewska-Koziell, J. F. Brien, and K. Nakatsu: Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine, but not by glyceryl trinitrate. Drug Metab. Dispos. 23, 1248-1252 (1995).
8. R. F. Furchgott: The 1989 Ulf von Euler lecture. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol. Scand. 139, 257-270 (1990).
9. R. J. Gryglewski, R. M. Palmer, and S. Moncada: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320, 454-456 (1986).
10. R. Radi, J. S. Beckman, and B. A. Freeman: Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244-4250 (1991).
11. M. Rubanyi and P. M. Vanhoutte: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250, H822-H827 (1986).
12. R. F. Furchgott: Endothelium-derived relaxing factor and nitric oxide. Can. J. Physiol. Pharmacol. 72 (Suppl. 1), 21 (abstr. S11.1) (1994).
13. 2 production by human neutrophils: the preparation and assay of NADPH oxidase containing particles from human neutrophils. Methods Enzymol. 105, 362-363 (1984).
14. M. Wu, K. Pritchard, P. Kaminski, R. Fayngersh, T. Hintze, and M. Wolin: Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am. J. Physiol. 266, H2108-H2113 (1994).
15. C. A. Gruetter, B. K. Barry, D. B. McNamara, D. Y. Gruetter, P. J. Kadowitz, and L. J. Ignarro: Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J. Cyclic Nucl. Res. 5, 211-224 (1979).
16. F. Murad, C. K. Mittal, W. P. Arnold, S. Katsuki, and H. Kimura: Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv. Cyclic Nucl. Res. 9, 145-148 (1978).
17. E. A. Kowaluk and H.-L. Fung: Spontaneous liberation of nitric oxide cannot account for in vivo vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255, 1256-1264 (1990).
18. J. Robak, E. Marcinkiewicz, R. Gryglewski, T. N. Corell, S. B. Petersen, and G. Karup: Scavenging of superoxide anions by nitric oxide donors. Pharmacol. Res. 25 (Suppl. 2), 355-356 (1992).
19. D. D. Ku, S. Liu, and J. S. Beckman: Peroxynitrite produces a potent vasorelaxation in human coronary arteries and transplanted coronary artery bypass grafts. Circ. Res. 86, I-619 (abstr.) (1992).
20. S. Liu, J. S. Beckman, and D. D. Ku: Coronary vascular effects of peroxynitrite. FASEB J. 12 (1992).
21. A. J. Hobbs, J. F. Tucker, and A. Gibson: Differentiation by hydroquinone of relaxations induced by exogenous and endogenous nitrates in non-vascular smooth muscle: role of superoxide anions. Br. J. Pharmacol. 104, 645-650 (1991).
22. S. J. Chung and H.-L. Fung: Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J. Pharmacol. Exp. Ther. 253, 614-619 (1990).
23. F. Kiechle and T. Malinski: Nitric oxide: biochemistry, pathophysiology, and detection. Am. J. Clin. Pharmacol. 10, 567-573 (1993).
24. V. G. Kharitonov, A. R. Sundquist, and V. S. Sharma: Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J. Biol. Chem. 270, 28158-28164 (1995).
25. J. S. Stamler and J. Loscalzo: S-Nitrosylation of proteins with nitric oxide synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U.S.A. 89, 444-448 (1992).
26. J. Keaney, D. I. Simon, J. S. Stamler, O. Jaraki, D. Scharfestein, J. Vita, and J. Loscalzo: NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91, 1582-1589 (1993).
27. W. R. Kukovetz, S. Holzmann, and K. Schmidt: Cellular mechanisms of action of therapeutic nitric oxide donors. Eur. Heart J. 12 (Suppl. E), 16-24 (1991).
28. J. S. Stamler, O. Jaraki, J. Osborne, D. I. Simon, J. Keaney, J. Vita, D. Singel, C. R. Valeri, and J. Loscalzo: Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A. 89, 7674-7677 (1992).
29. J. P. Cooke, J. Stamler, N. Andon, P. F. Davies, and J. Loscalzo: Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am. J. Physiol. 259, H804-H812 (1990).
30. B. Gaston, J. Reilly, J. M. Drazen, J. Fackler, P. Ramdev, D. Arnelle, M. E. Mullins, D. J. Sugarbaker, C. Chee, D. J. Singel, J. Loscalzo, and J. S. Stamler: Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. U.S.A. 90, 10957-10961 (1993).
31. C. M. Venturini, R. M. J. Palmer, and S. Moncada: Vascular smooth muscle contains a depletable store of a vasodilator which is light-activated and restored by donors of nitric oxide. J. Pharmacol. Exp. Ther. 266, 1497-1500 (1993).
32. D. L. H. Williams: S-nitrosation and the reactions of S-nitroso compounds. Chem. Soc. Rev. 14, 171-196 (1985).
33. 2. Fed. Proc. 39, 743 (1980).
34. W. Mathews and S. Kerr: Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther. 267, 1529-1537 (1993).